Sarah S. Donaldson, M.D.

Publications

• Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer. Kovalchik SA, Ronckers CM, Veiga LH, Sigurdson AJ, Inskip PD, de Vathaire F, Sklar CA, Donaldson SS, Anderson H, Bhatti P, Hammond S, Leisenring WM, Mertens AC, Smith SA, Stovall M, Tucker MA, Weathers RE, Robison LL, Pfeiffer RM. J Clin Oncol. 2013; 31 (1): 119-27
• Changes in health status among aging survivors of pediatric upper and lower extremity sarcoma: a report from the childhood cancer survivor study. Marina N, Hudson MM, Jones KE, Mulrooney DA, Avedian R, Donaldson SS, Popat R, West DW, Fisher P, Leisenring W, Stovall M, Robison LL, Ness KK. Arch Phys Med Rehabil. 2013; 94 (6): 1062-73
• Low-Dose Radiation Therapy (2 Gy × 2) in the Treatment of Orbital Lymphoma. Fasola CE, Jones JC, Huang DD, Le QT, Hoppe RT, Donaldson SS. Int J Radiat Oncol Biol Phys. 2013
• A tribute to Malcolm A. Bagshaw--an innovative physician who soared to success. Hoppe RT, Donaldson SS. Int J Radiat Oncol Biol Phys. 2012; 83 (1): 6-7
• Finding the balance in pediatric Hodgkin's lymphoma. Donaldson SS, J Clin Oncol. 2012; 30 (26): 3158-9
• Resectable pediatric nonrhabdomyosarcoma soft tissue sarcoma: which patients benefit from adjuvant radiation therapy and how much? Million L, Donaldson SS. ISRN Oncol. 2012: 2012 341408
• Risk factors for obesity in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Green DM, Cox CL, Zhu L, Krull KR, Srivastava DK, Stovall M, Nolan VG, Ness KK, Donaldson SS, Oeffinger KC, Meacham LR, Sklar CA, Armstrong GT, Robison LL. J Clin Oncol. 2012; 30 (3): 246-55
• Controversies in radiotherapy for pediatric Hodgkin's lymphoma. Wiegner EA, Donaldson SS. Expert Rev Anticancer Ther. 2011; 11 (9): 1357-66
• In Reply to Dr. Nishida et al. Donaldson SS, La TH. Int J Radiat Oncol Biol Phys. 2011; 81 (2): 606
• Local therapy for rhabdomyosarcoma of the hands and feet: is amputation necessary? A report from the Children's Oncology Group. La TH, Wolden SL, Su Z, Linardic C, Randall RL, Hawkins DS, Donaldson SS. Int J Radiat Oncol Biol Phys. 2011; 80 (1): 206-12
• Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group. Rodeberg DA, Garcia-Henriquez N, Lyden ER, Davicioni E, Parham DM, Skapek SX, Hayes-Jordan AA, Donaldson SS, Brown KL, Triche TJ, Meyer WH, Hawkins DS. J Clin Oncol. 2011; 29 (10): 1304-11
• Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group. La TH, Wolden SL, Rodeberg DA, Hawkins DS, Brown KL, Anderson JR, Donaldson SS. Int J Radiat Oncol Biol Phys. 2011; 80 (4): 1151-7
• Early treatment failure in intermediate-risk rhabdomyosarcoma: results from IRS-IV and D9803--a report from the Children's Oncology Group. Minn AY, Lyden ER, Anderson JR, Million L, Arndt CA, Brown K, Hawkins DS, Donaldson SS. J Clin Oncol. 2010; 28 (27): 4228-32
• Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, Donaldson SS, Byrne J, Robison LL. J Clin Oncol. 2010; 28 (2): 332-9
• Randomized phase II window trial of two schedules of irinotecan with vincristine in patients with first relapse or progression of rhabdomyosarcoma: a report from the Children's Oncology Group. Mascarenhas L, Lyden ER, Breitfeld PP, Walterhouse DO, Donaldson SS, Paidas CN, Parham DM, Anderson JR, Meyer WH, Hawkins DS. J Clin Oncol. 2010; 28 (30): 4658-63
• Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy. O'Brien MM, Donaldson SS, Balise RR, Whittemore AS, Link MP. J Clin Oncol. 2010; 28 (7): 1232-9
• Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP. J Natl Cancer Inst. 2010; 102 (14): 1083-95
• External beam radiation therapy enhances local control in pigmented villonodular synovitis. Horoschak M, Tran PT, Bachireddy P, West RB, Mohler D, Beaulieu CF, Kapp DS, Donaldson SS. Int J Radiat Oncol Biol Phys. 2009; 75 (1): 183-7
• Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, Donaldson SS, Byrne J, Robison LL. J Clin Oncol. 2009; 27 (16): 2677-85
• High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. Hudson MM, Mulrooney DA, Bowers DC, Sklar CA, Green DM, Donaldson SS, Oeffinger KC, Neglia JP, Meadows AT, Robison LL. J Clin Oncol. 2009; 27 (14): 2405-14
• Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. Armstrong GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W, Hudson MM, Donaldson SS, King AA, Stovall M, Krull KR, Robison LL, Packer RJ. J Natl Cancer Inst. 2009; 101 (13): 946-58
• Radiation dose and breast cancer risk in the childhood cancer survivor study. Inskip PD, Robison LL, Stovall M, Smith SA, Hammond S, Mertens AC, Whitton JA, Diller L, Kenney L, Donaldson SS, Meadows AT, Neglia JP. J Clin Oncol. 2009; 27 (24): 3901-7
• Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, Hammond S, Yasui Y, Inskip PD. J Clin Oncol. 2009; 27 (14): 2356-62
• The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. Robison LL, Armstrong GT, Boice JD, Chow EJ, Davies SM, Donaldson SS, Green DM, Hammond S, Meadows AT, Mertens AC, Mulvihill JJ, Nathan PC, Neglia JP, Packer RJ, Rajaraman P, Sklar CA, Stovall M, Strong LC, Yasui Y, Zeltzer LK. J Clin Oncol. 2009; 27 (14): 2308-18
• Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803. Arndt CA, Stoner JA, Hawkins DS, Rodeberg DA, Hayes-Jordan AA, Paidas CN, Parham DM, Teot LA, Wharam MD, Breneman JC, Donaldson SS, Anderson JR, Meyer WH. J Clin Oncol. 2009; 27 (31): 5182-8
• Treatment of pediatric hodgkin lymphoma. Olson MR, Donaldson SS. Curr Treat Options Oncol. 2008; 9 (1): 81-94
• Understanding the risk of second malignant tumors in children with Hodgkin's disease. Donaldson SS, O'Brien MM. Int J Radiat Oncol Biol Phys. 2008; 72 (1): 4-5
• Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. Donaldson SS, Link MP, Weinstein HJ, Rai SN, Brain S, Billett AL, Hurwitz CA, Krasin M, Kun LE, Marcus KC, Tarbell NJ, Young JA, Hudson MM. J Clin Oncol. 2007; 25 (3): 332-7
• Advances toward an understanding of brainstem gliomas. Donaldson SS, Laningham F, Fisher PG. J Clin Oncol. 2006; 24 (8): 1266-72
• Ewing sarcoma: radiation dose and target volume. Donaldson SS, Pediatr Blood Cancer. 2004; 42 (5): 471-6
• Failure Pattern and Factors Predictive of Local Failure in Rhabdomyosarcoma: A Report of Group III Patients on the Third Intergroup Rhabdomyosarcoma Study Wharam MD, Meza J, Anderson J, Breneman JC, Donaldson SS, Fitzgerald TJ, Michalski J, Teot LA, Wiener ES, Meyer WH. Journal of Clinical Oncology. 2004: 22 1902-1908
• Genetic Effects of Radiotherapy for Childhood Cancer: Gonadal Dose Reconstruction Stovall M, Donaldson S, Weathers RE, Robison LL, Mertens AC, Winther JF, Olsen JH, Boice JD. International Journal of Radiation Oncology, Biology, and Physics. 2004: 60 542-552
• High-dose Therapy and Autologous Hemapoietic Stem-cell Transplantation for Recurrent or Refractory Pediatric Hodgkin's Disease: Results and Prognostic Indices Lieskovsky YYE, Donaldson SS, Torres MA, Wong RM, Amylon MD, Link MP, Agarwal R. Journal of Clinical Oncology. 2004: 22 4532-4540
• Influence of Radiation Therapy Parameters on Outcome in Children Treated with Radiation Therapy for Localized Parameningeal Rhabdomyosarcoma in the Intergroup Rhabdomyosarcoma Study Group Trials II through IV Michalski JM, Meza J, Breneman JC, Wolden SL, Laurie F, Jodoin MA, Raney B, Wharam MD, Donaldson SS. International Journal of Radiation Oncology, Biology, and Physics. 2004: 59 1027-1038
• Risk-adapted Combined-modality Therapy with VAMP/COP and Response-based Involved-field Radiation for Unfavorable Pediatric Hodgkin's Disease Hudson MM, Krasin M, Link MP, Donaldson SS, Billups C, Merchant TE, Kun L, Billey AL, Kaste S, Tarbell NJ, Howard S, Friedman AM, Hurwitz CA, Young JA, Marcus KC, Rai S, Cowen T, Weinstein HJ. Journal of Clinical Oncology. 2004: 22 4541-4550
• Subspecialty training and certification for radiation oncology. Donaldson SS, Halperin EC. J Am Coll Radiol. 2004; 1 (7): 488-92
• A Discourse: The 2002 Wataru W. Sutow Lecture; Hodgkin's Disease in Children: Perspectives and Progress Donaldson SS, Medical and Pediatric Oncology. 2003: 40 73-81
• A discourse: the 2002 Wataru W. Sutow lecture. Hodgkin disease in children--perspectives and progress. Donaldson SS, Med Pediatr Oncol. 2003; 40 (2): 73-81
• Genetic Effects of Radiotherapy for Childhood Cancer Boice JD, Tawn EJ, Winther JF, Donaldson SS, Green DM, Mertens AC, Mulvihill JJ, Olsen JH, Robison LL, Stovall M. Health Physics. 2003; 85 (1): 65-80
• Prognostic Factors for Children with Hodgkin's Disease Treated with a Combined Modality Therapy Smith RS, Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, Billen A, Marcus KJ, Tarbell NJ, Donaldson SS. Journal of Clinical Oncology. 2003: 21 2026-2033
• Pediatric Hodgkin's Disease: Up, Up and Beyond Donaldson SS, International Journal of Radiation Oncology, Biology, and Physics. 2002: 54 1-8
• Pediatric Hodgkin's disease--up, up, and beyond. Donaldson SS, Int J Radiat Oncol Biol Phys. 2002; 54 (1): 1-8
• Study Design and Cohort Characteristics of the Childhood Cancer Survivor Study: A Multi-institutional Collaborative Project Robinson LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, Li FP, Meadows AT, Mulvihill JJ, Neglia JP, Nesbit ME, Packer RJ, Potter JD, Sklar CA, Smith MA, Stovall M, Strong LC, Yasui Y, Zeltser L. Medical and Pediatric Oncology. 2002: 38 229-239
• VAMP and Low-dose, Involved-field Radiation for Children and Adolescents with Favorable, Early-stage Hodkin's Disease: Results of a Prospective Clinical Trial Donaldson SS, Hudson MM, Lamborn KR, Link MP, Kun L, Billett AL, Marcus KC, Hurwitz CA, Young JA, Tarbell NJ, Weinstein HJ. Journal of Clinical Oncology. 2002: 20 3081-3087
• VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. Donaldson SS, Hudson MM, Lamborn KR, Link MP, Kun L, Billett AL, Marcus KC, Hurwitz CA, Young JA, Tarbell NJ, Weinstein HJ. J Clin Oncol. 2002; 20 (14): 3081-7
• Intergroup Rhabdomyosarcoma Study IV: Results for Patients with Non-metastatic Disease Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualmann SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS. Journal of Clinical Oncology. 2001: 19 3091-3102
• Long-term Results of Irradiation for Patients with Progressive Graves' Ophthalmopathy Marquez SD, Lum BL, McDougall IR, Katkuri S, Levin PS, MacManus M, Donaldson SS. International Journal of Radiation Oncology, Biology, and Physics. 2001: 51 766-774
• Long-term results of irradiation for patients with progressive Graves' ophthalmopathy. Marquez SD, Lum BL, McDougall IR, Katkuri S, Levin PS, MacManus M, Donaldson SS. Int J Radiat Oncol Biol Phys. 2001; 51 (3): 766-74
• Results from the IRS IV Randomized Trial of Hyperfractionated Radiotherapy in Children with Rhabdomyosarcoma: A Report from the IRSG Donaldson SS, Meza J, Breneman JC, Crist WM, Laurie F, Qualman SJ, Wharam M. International Journal of Radiation Oncology, Biology, and Physics. 2001: 51 718-728
• Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG. Donaldson SS, Meza J, Breneman JC, Crist WM, Laurie F, Qualman SJ, Wharam M. Int J Radiat Oncol Biol Phys. 2001; 51 (3): 718-28
• Second Malignant Neoplasms in Five-Year Survivors of Childhood Cancer: Childhood Cancer Survivor Study Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL. Journal of the National Cancer Institute. 2001: 93 618-29
• The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons from the IRS-I through IRS-IV Studies as Background for the Current IRS-V Treatment Protocol Sarcoma Raney, RB, Maurer HM, Anderson JR, Andrassy RJ, Donaldson SS, Qualman SJ, Wharam MD, Wiener ES, Crist WM. Sarcoma. 2001: 5 9-15
• Soft-tissue Sarcomas of the Diaphragm: From the Intergroup Rhabdomyosarcoma Study Group from 1972-1977 Raney RB, Anderson JR, Andrassy RJ, Crist WM, Donaldson SS, Maurer HM. Journal of Pediatric Hematology and Oncology. 2000: 22 510-514
• Topography of childhood tumors: pediatric coding system. Donaldson SS, Draper GJ, Flamant F, Gerard-Marchant R, Mouriesse H, Newton WA, Lemerle J. Pediatr Hematol Oncol. 1986; 3 (3): 249-58